We used a polyethylimine-based cationic polymer, JetPEI (Polyplus) as an encapsulation agent for the in vivo delivery agent for FOXM1-siRNA by direct intratumoral injection at a dose of 10 μg siRNA/tumor, 3 times per week [34]. The gene discussed is FOXM1; the disease is neoplasm.